Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2012
10/04/2012CA2831427A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan
10/04/2012CA2830831A1 Macrocyclic compounds and methods for their production
10/04/2012CA2830827A1 Macrocyclic compound and methods for its production
10/03/2012EP2504344A1 Hepatitis c inhibitor compounds
10/03/2012CN102712644A Novel macrocyclic inhibitors of hepatitis C virus replication
10/03/2012CN102707070A Agent with kokumi
10/03/2012CN102702311A Agent with kokumi
10/03/2012CN102702310A Marine peptides compounds and application of marine peptides compounds to preparation of angiogenesis medicines
10/03/2012CN102079771B Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof
10/03/2012CN101920196B Hydrogenation catalyst for synthesizing neotame and preparation method thereof
10/03/2012CN101668778B Preparation of low bleeding anticoagulant fusion protein and its use
10/03/2012CN101580535B Hcv protease inhibitors
10/03/2012CN101400368B Cancer treatment using viruses, fluoropyrimidines and camptothecins
10/02/2012CA2526629C Process and intermediates for the preparation of (1r,2s,5s)-3-azabicyclo[3,1,0]hexane-2-carboxamide, n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl
09/2012
09/27/2012WO2012129473A1 Gallium complexes, pharmaceutical compositions and methods of use
09/27/2012WO2012128464A1 Undecenoyl dipeptide derivatives, and skin whitening cosmetic composition containing same
09/27/2012WO2012128438A1 Palmitoyl dipeptide in which glycylproline or glycylhydroxyproline is bonded to palmitic acid, and a production method therefor
09/27/2012US20120245091 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
09/27/2012US20120244174 Treatment of tauopathies
09/27/2012US20120244122 Peptides for the Treatment of HCV Infections
09/26/2012EP2502906A2 Trypsin-like serine protease inhibitors, their preparation and use
09/26/2012EP2501823A1 Method for the production of extracellular glutathione with high yields
09/26/2012CN1914225B HCV NS-3 serine protease inhibitors
09/26/2012CN102695714A Tubulin inhibitors
09/26/2012CN102690327A Enterovirus 71 neutralized epitope polypeptide and application thereof
09/26/2012CN102690326A Novel gossypol derivate with anti-HIV activity and preparation method thereof
09/26/2012CN102690325A Synthesis of polypeptide PyroGlu-Pro-Arg-pNA.HCl
09/26/2012CN101962400B Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof
09/25/2012US8273530 Method for simultaneous analysis of multiple biological reactions or changes in in vivo conditions
09/25/2012CA2466591C Template-fixed peptidomimetics as inhibitors of serine proteases
09/25/2012CA2405268C Dna molecules encoding l-glutamate-gated chloride channels from rhipicephalus sanguineus
09/25/2012CA2336236C Mutations in and genomic structure of herg - a long qt syndrome gene
09/20/2012WO2012123957A1 Oligopeptides and process for preparation thereof
09/20/2012WO2012123423A1 N-carboxyalkyl-auristatins and use thereof
09/20/2012WO2012098546A8 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
09/20/2012WO2012076985A8 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
09/20/2012US20120238749 Inhibitors of interleukin-1 beta converting enzyme
09/20/2012US20120238503 Human laminin alpha2 chain lg3 domain and active peptides promoting cell adhesion, spreading, migration, and neurite outgrowth
09/20/2012US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
09/20/2012CA2829736A1 N-carboxyalkylauristatins and use thereof
09/19/2012EP2500029A1 Therapeutic agent for gastrointestinal diseases
09/19/2012EP2499153A1 Tubulin inhibitors
09/19/2012EP2499152A1 Tubulin inhibitors
09/19/2012CN102686602A Lanthionine derivative
09/19/2012CN102675418A Luteinizing hormone-releasing hormone (LHRH) antagonist derivative, preparation method of LHRH antagonist derivative and application of LHRH antagonist derivative
09/19/2012CN102675417A Monocyte migration inhibition factor analogue, synthesis thereof and application thereof
09/19/2012CN102675416A Beta-carboline derivatives, and preparation method and application thereof
09/19/2012CN102675415A Method for preparing bortezomib
09/19/2012CN102671181A High purity lipopeptides, lipopeptide micelles and processes for preparing same
09/18/2012US8268798 Low density lipoprotein receptor-mediated siRNA delivery
09/18/2012CA2451133C Therapeutic agent for sepsis
09/18/2012CA2410662C Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
09/13/2012WO2012121428A1 Fibroblast growth composition comprising a dipeptide as an active ingredient, and a product comprising the composition
09/13/2012US20120232248 Therapeutic agent for pulmonary small cell carcinoma
09/13/2012US20120232247 Processes for preparing protease inhibitors of hepatitis c virus
09/13/2012DE102011005288A1 Producing protein hydrolyzate, useful as angiotensin converting enzyme inhibitor, comprises enzymatically hydrolyzing protein containing substrate in two treatment steps with different proteolytic enzymes
09/12/2012EP2497765A1 Process for preparing creatine amides
09/12/2012EP2496596A1 Therapeutic peptides
09/12/2012CN102665768A Peptide clearing agents
09/12/2012CN102665749A Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
09/12/2012CN102665452A Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) -
09/12/2012CN102665451A Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3s,6s)-
09/12/2012CN102660615A Antioxidant peptide and preparation method thereof
09/12/2012CN102659920A C-end phenylalanine p-amino modified endomorphine-1 analog and preparation and application thereof
09/12/2012CN102659919A Synthetic method of bortezomib
09/12/2012CN102659918A Graphene/dipeptide self-assembly composite film and preparation method thereof
09/12/2012CN102241674B Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester
09/11/2012US8263738 Estrogen receptors and methods of use
09/11/2012US8263548 Metal-binding compounds and uses therefor
09/11/2012US8263547 DISC-1 pathway activators in the control of neurogenesis
09/11/2012CA2549851C Macrocyclic peptides active against the hepatitis c virus
09/11/2012CA2465245C Biologically active peptides and their use for repairing injured nerves
09/07/2012WO2012117136A1 Lactoferrin hydrolysate fraction with a low molecular weight for treating hypertension
09/07/2012WO2012097333A3 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
09/07/2012WO2012047354A3 Environmentally sensitive compositions
09/06/2012US20120226072 Processes for intermediates for macrocyclic compounds
09/06/2012US20120226067 Processes for intermediates for macrocyclic compounds
09/06/2012US20120226066 Processes for intermediates for macrocyclic compounds
09/06/2012US20120225830 Method of producing fr901228
09/06/2012US20120225829 Method of producing fr901228
09/06/2012US20120225817 Therapeutic agent for gastrointestinal disease
09/05/2012EP2495250A2 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
09/05/2012EP2495249A1 Tertiary amine substituted peptides useful as inhibitors of HCV replication
09/05/2012EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
09/05/2012CN1956994B Epithelial cell growth promoter
09/05/2012CN101899084B (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid kyrine conjugate, preparation method and application thereof
09/05/2012CN101696231B Antigen epitope minimum motif peptide of human papilloma virus 58 type E6 protein
09/05/2012CN101627049B Synthetic peptide amides
09/04/2012US8258256 Compositions and methods for the treatment of cancer
09/04/2012US8258101 Peptide-based compounds
09/04/2012US8257943 Process for producing dipeptides or dipeptide derivatives
09/04/2012CA2615022C Hcv ns3 protease inhibitors
08/2012
08/30/2012US20120220752 Tri-amino releasing fulvate
08/30/2012US20120219501 Biomarker en2 for gynaecological cancer
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/29/2012EP2492278A1 Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy
08/29/2012EP2491943A2 Methods for preventing mitochondrial permeability transition
08/29/2012EP2491051A2 Gadd45beta targeting agents
08/29/2012EP2490766A1 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
08/29/2012EP2008664B1 Modified proteins which bind extracellular matrix components
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 307